Ventrus Biosciences, Inc. (VTUS) Announces Proposed Public Offerings of Common Stock and Series A Convertible Preferred Stock
1/30/2013 9:35:44 AM
More...
|
Ventrus Biosciences, Inc. (VTUS) Announces $20 Million Financing
1/30/2013 9:27:38 AM
More...
|
Ventrus Biosciences, Inc. (VTUS) Reports Third Quarter 2012 Financial Results
11/14/2012 7:39:35 AM
More...
|
Ventrus Biosciences, Inc. (VTUS) to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
11/9/2012 10:18:59 AM
More...
|
Ventrus Biosciences, Inc. (VTUS) Receives FDA Written Feedback, Targets NDA Filing for Diltiazem (VEN 307) in Anal Fissures Following Second Phase 3 Study
11/5/2012 9:32:03 AM
More...
|
Ventrus Biosciences, Inc. (VTUS) Appoints JP Benya Vice President, Commercial Operations and Business Development
9/24/2012 9:46:54 AM
More...
|
Ventrus Biosciences, Inc. (VTUS) to Present at Upcoming Investor Conferences in September
8/29/2012 9:20:21 AM
More...
|
Ventrus Biosciences, Inc. (VTUS) Reports Second Quarter 2012 Financial Results
8/10/2012 9:59:07 AM
More...
|
Ventrus Biosciences, Inc. (VTUS) Down Over 50% After Phase 3 Failure
6/25/2012 7:02:47 AM
More...
|
Ventrus Biosciences, Inc. (VTUS) to Present at the Jefferies and Co. 2012 Global Healthcare Conference
5/30/2012 9:18:31 AM
More...
|
|